Small Molecules—Prospective Novel HCMV Inhibitors
Human cytomegalovirus (HCMV), a member of the betaherpesvirinae, can cause life-threatening diseases. HCMV is globally widespread, with a seroprevalence in adults varying from 50 to 100%. HCMV infection is rarely of significant consequence in immunocompetent individuals. However, although immune con...
Main Authors: | Elke Bogner, Anna Egorova, Vadim Makarov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/3/474 |
Similar Items
-
Exploring the Human Cytomegalovirus Core Nuclear Egress Complex as a Novel Antiviral Target: A New Type of Small Molecule Inhibitors
by: Sewar Alkhashrom, et al.
Published: (2021-03-01) -
CARs—A New Perspective to HCMV Treatment
by: Christopher Bednar, et al.
Published: (2021-08-01) -
HCMV Antivirals and Strategies to Target the Latent Reservoir
by: Marianne R. Perera, et al.
Published: (2021-05-01) -
Small molecule inhibitors targeting the cancers
by: Gui‐Hong Liu, et al.
Published: (2022-12-01) -
Therapeutic targeting of HCMV-encoded chemokine receptor US28: Progress and challenges
by: Christian Berg, et al.
Published: (2023-02-01)